Suppr超能文献

通过转录激活和同源重组修复测定对罕见种系 BRCA1 变体进行功能分析。

Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.

机构信息

Department of Medical Genetics, Division of Child and Adolescent Health, University Hospital of North Norway, Tromsø, Norway.

Familial Cancer Center, Haukeland University Hospital, Bergen, Norway.

出版信息

BMC Cancer. 2023 Apr 21;23(1):368. doi: 10.1186/s12885-023-10790-w.

Abstract

BACKGROUND

Damaging alterations in the BRCA1 gene have been extensively described as one of the main causes of hereditary breast and ovarian cancer (HBOC). BRCA1 alterations can lead to impaired homologous recombination repair (HRR) of double-stranded DNA breaks, a process which involves the RING, BRCT and coiled-coil domains of the BRCA1 protein. In addition, the BRCA1 protein is involved in transcriptional activation (TA) of several genes through its C-terminal BRCT domain.

METHODS

In this study, we have investigated the effect on HRR and TA of 11 rare BRCA1 missense variants classified as variants of uncertain clinical significance (VUS), located within or in close proximity to the BRCT domain, with the aim of generating additional knowledge to guide the correct classification of these variants. The variants were selected from our previous study "BRCA1 Norway", which is a collection of all BRCA1 variants detected at the four medical genetic departments in Norway.

RESULTS

All variants, except one, showed a significantly reduced HRR activity compared to the wild type (WT) protein. Two of the variants (p.Ala1708Val and p.Trp1718Ser) also exhibited low TA activity similar to the pathogenic controls. The variant p.Trp1718Ser could be reclassified to likely pathogenic. However, for ten of the variants, the total strength of pathogenic evidence was not sufficient for reclassification according to the CanVIG-UK BRCA1/BRCA2 gene-specific guidelines for variant interpretation.

CONCLUSIONS

When including the newly achieved functional evidence with other available information, one VUS was reclassified to likely pathogenic. Eight of the investigated variants affected only one of the assessed activities of BRCA1, highlighting the importance of comparing results obtained from several functional assays to better understand the consequences of BRCA1 variants on protein function. This is especially important for multifunctional proteins such as BRCA1.

摘要

背景

BRCA1 基因的破坏性改变已被广泛描述为遗传性乳腺癌和卵巢癌 (HBOC) 的主要原因之一。BRCA1 改变可导致双链 DNA 断裂的同源重组修复 (HRR) 受损,该过程涉及 BRCA1 蛋白的 RING、BRCT 和卷曲螺旋结构域。此外,BRCA1 蛋白通过其 C 端 BRCT 结构域参与多个基因的转录激活 (TA)。

方法

在这项研究中,我们研究了 11 种位于 BRCT 结构域内或附近的 BRCA1 错义变异体的 HRR 和 TA 效应,这些变异体被归类为不确定临床意义的变异体 (VUS),旨在生成更多的知识来指导这些变异体的正确分类。这些变体是从我们之前的研究“BRCA1 Norway”中选择的,这是一个在挪威四个医学遗传部门检测到的所有 BRCA1 变体的集合。

结果

除一个变体外,所有变体与野生型 (WT) 蛋白相比,HRR 活性均显著降低。两个变体 (p.Ala1708Val 和 p.Trp1718Ser) 也表现出与致病性对照相似的低 TA 活性。变体 p.Trp1718Ser 可以重新归类为可能致病性。然而,对于十个变体,根据 CanVIG-UK BRCA1/BRCA2 基因特异性变异解释指南,总致病性证据的强度不足以重新分类。

结论

当包括新获得的功能证据和其他可用信息时,一个 VUS 被重新归类为可能致病性。在所研究的 11 个变体中,有 8 个仅影响 BRCA1 评估的一个活动,这突出了比较来自几个功能测定的结果以更好地理解 BRCA1 变体对蛋白质功能的影响的重要性。对于 BRCA1 等多功能蛋白来说尤其重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0a/10122298/de8311e94cad/12885_2023_10790_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验